Direkt zum Inhalt | Direkt zur Navigation

Benutzerspezifische Werkzeuge

Sektionen
Studienregister
Sie sind hier: Startseite / Klinische Studien / Studienregister

Studienregister

GMALL Register

AcronymISRCTNEudraCTClinicaltrials.govDRKS
GMALL Registern/an/an/an/a

GMALL registry and biomaterial bank: biomaterial collection and prospective data collection on diagnosis, treatment and disease course of adult ALL

Status: Active

Purpose / Objectives

Primary Outcome

  • Input features and prognostic factors
  • Disease status and selected therapies
  • Course of therapy, including the overall and disease-free survival, response rate and duration of different treatments and patient subgroups
  • Data for treatment with newer forms of therapy and use of newer supportive drugs
  • Quality of life at different times
  • Therapy and late effects
  • Quality of diagnosis and treatment of ALL

 

Secondary Outcomes

For as many questions conduct prospective treatment studies and also to allow as many clinics participating in these studies

 

Diagnosis

Acute lymphoblastic leukemia

 

Patient attributes

Age

18-99

Inclusion criteria

  • acute lymphatic leukemia or
  • other leukaemias (NK cell lymphoma/leukaemia, acute biphenotypic leukaemia) or
  • Non-Hodgkin lymphomas of the following subtypes (WHO classification): Burkitt's lymphoma (including atypical Burkitt lymphoma, Burkitt-like lymphoma), diffuse large B-cell lymphomas (in particular primarily mediastinal DLBCL, DLBCL with Burkitt signature, c-myc-positive DLBCL), B-lymphoblastic lymphoma, T-lymphoblastic lymphoma, large cell anaplastic lymphoma, other NHL
  • Age ≥ 18 years
  • Written consent of the patient

Exclusion criteria

none

Trial design

  • Multicenter
  • Prospective

Intervention

no study therapy

Documents (password protected)

Responsibilities in overall trial

GMALL-Studiengruppe

National Coordinating Investigator

Dr. med. Nicola Gökbuget

Study Sites

Klinik I für Innere Medizin

Study office

  • Klinisches Studienzentrum der Klinik I für Innere Medizin Köln

Status

Active

Principal Investigator

Prof. Dr. med. Hans Christian Reinhardt

Contact at Site